Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

243 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Typhoid conjugate vaccine perceptions and coverage among children and adults: Findings from a post-campaign coverage survey - Harare, Zimbabwe, 2019.
Gharpure R, Longley AT, Takamiya M, Hidle A, Munyanyi M, Chawurura T, Maxwell L, Mamire G, Chaora G, Chakauya J, Rupfutse M, Poncin M, Gasasira A, Date K, Manangazira P, Sreenivasan N. Gharpure R, et al. Among authors: date k. Vaccine. 2024 Oct 24;42(24):126086. doi: 10.1016/j.vaccine.2024.06.053. Epub 2024 Jul 10. Vaccine. 2024. PMID: 38991917
Field Effectiveness of a Typhoid Conjugate Vaccine: The 2018 Navi Mumbai Pediatric TCV Campaign.
Date K, LeBoa C, Hoffman SA, Haldar P, Harvey P, An Q, Zhang C, Yewale VN, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Shimpi R, Jayaprasad N, Horng L, Fagerli K, Borhade P, Chakraborty D, Katkar A, Kunwar A, Andrews JR, Bahl S, Bhatnagar P, Dutta S, Luby SP. Date K, et al. Am J Trop Med Hyg. 2024 Aug 13;111(4):848-852. doi: 10.4269/ajtmh.24-0181. Print 2024 Oct 2. Am J Trop Med Hyg. 2024. PMID: 39137766 Free PMC article.
Factors Influencing Vaccine Receipt During a 2018 Pediatric Typhoid Conjugate Vaccine Campaign in Navi Mumbai, India.
Borhade P, LeBoa C, Jayaprasad N, Date K, Haldar P, Harvey P, Shimpi R, An Q, Zhang C, Horng L, Fagerli K, Yewale VN, Daruwalla S, Dharmapalan D, Gavhane J, Joshi S, Rai R, Rathod V, Shetty K, Warrier DS, Yadav S, Chakraborty D, Bahl S, Katkar A, Kunwar A, Andrews JR, Bhatnagar P, Dutta S, Luby SP, Hoffman SA. Borhade P, et al. Among authors: date k. Am J Trop Med Hyg. 2024 Sep 3;111(5):1060-1065. doi: 10.4269/ajtmh.24-0182. Print 2024 Nov 6. Am J Trop Med Hyg. 2024. PMID: 39348826 Free PMC article.
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009.
Jain S, Kamimoto L, Bramley AM, Schmitz AM, Benoit SR, Louie J, Sugerman DE, Druckenmiller JK, Ritger KA, Chugh R, Jasuja S, Deutscher M, Chen S, Walker JD, Duchin JS, Lett S, Soliva S, Wells EV, Swerdlow D, Uyeki TM, Fiore AE, Olsen SJ, Fry AM, Bridges CB, Finelli L; 2009 Pandemic Influenza A (H1N1) Virus Hospitalizations Investigation Team. Jain S, et al. N Engl J Med. 2009 Nov 12;361(20):1935-44. doi: 10.1056/NEJMoa0906695. Epub 2009 Oct 8. N Engl J Med. 2009. PMID: 19815859 Free article.
Randomised, placebo-controlled, double-blinded, four-way crossover trial to demonstrate the comparative pharmacodynamic equivalence of a non-invasive diagnostic test for adrenal insufficiency in a healthy population: the STARLIT-2 study protocol.
Date KL, Baster K, Caunt SL, Cohen J, Debono M, Fearnside J, Johnson TN, Ross RJ, Taylor RN, Elder CJ. Date KL, et al. BMJ Open. 2024 Dec 22;14(12):e094830. doi: 10.1136/bmjopen-2024-094830. BMJ Open. 2024. PMID: 39806610 Free PMC article. Clinical Trial.
Clinical impact of cancer cachexia on the outcome of patients with non-small cell lung cancer with PD-L1 tumor proportion scores of ≥50% receiving pembrolizumab monotherapy versus immune checkpoint inhibitor with chemotherapy.
Kawachi H, Yamada T, Tamiya M, Negi Y, Kijima T, Goto Y, Nakao A, Shiotsu S, Tanimura K, Takeda T, Okada A, Harada T, Date K, Chihara Y, Hasegawa I, Tamiya N, Katayama Y, Nishioka N, Morimoto K, Iwasaku M, Tokuda S, Shimose T, Takayama K. Kawachi H, et al. Among authors: date k. Oncoimmunology. 2025 Dec;14(1):2442116. doi: 10.1080/2162402X.2024.2442116. Epub 2024 Dec 16. Oncoimmunology. 2025. PMID: 39681395 Free PMC article.
YAP regulates HER3 signaling-driven adaptive resistance to RET inhibitors in RET-aberrant cancer.
Katayama Y, Yamada T, Tanimura K, Kawachi H, Ishida M, Matsui Y, Hirai S, Nakamura R, Morimoto K, Furuya N, Arai S, Goto Y, Sakata Y, Nishino K, Tsuchiya M, Tamiya A, Saito G, Muto S, Takeda T, Date K, Fujisaka Y, Watanabe S, Fujimoto D, Uehara H, Horinaka M, Sakai T, Yano S, Tokuda S, Takayama K. Katayama Y, et al. Among authors: date k. Clin Cancer Res. 2024 Nov 4. doi: 10.1158/1078-0432.CCR-24-1762. Online ahead of print. Clin Cancer Res. 2024. PMID: 39495173
243 results